PAR 1.96% 26.0¢ paradigm biopharmaceuticals limited..

General OA media and info, page-177

  1. 54 Posts.
    lightbulb Created with Sketch. 46
    Afternoon all, happy Tuesday!
    Not sure I remember seeing this one come through before, but I have been a little slack on keeping up with fully digesting my Mozz research notes of late.
    Although this isn't a PAR specific article, it gives a little teaser into a Columbia/Cambridge university research collaboration into existing Arthritus medication (Anakinra) having anti-aging properties through the blocking (ahem - down-regulation is a much sexier terminology) of IL-1B, and subsequent production of more youthful blood by the stem-cells within bone marrow.

    While I don't consider myself elderly yet, I do personally intend to live forever, and it would be wonderful to have a magical Arthritis medication that down-regulates IL-1B keep my own blood healthy ... rather than needing regular youthful blood transfusions, like a creepy vampire.

    Will Revitalizing Old Blood Slow Aging? | Columbia University Irving Medical Center - https://www.cuimc.columbia.edu/news/will-revitalizing-old-blood-slow-aging

    Also a link to the published research in Nature, that I'm personally a little too cheap to buy for myself. https://www.nature.com/articles/s41556-022-01053-0

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
0.005(1.96%)
Mkt cap ! $90.94M
Open High Low Value Volume
26.0¢ 27.0¢ 25.5¢ $154.0K 594.7K

Buyers (Bids)

No. Vol. Price($)
1 851 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 11145 3
View Market Depth
Last trade - 15.59pm 30/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.